Cutaneous photosynthesis of vitamin D: An evolutionary highly-conserved endocrine system that protects against environmental hazards including UV-radiation and microbial infections

Anticancer Research

Volumn 26, Issue 4 A, 2006, Pages 2743-2748

  Tremezaygues, Lea ^a   Sticherling, Michael ^b   Pföhler, Claudia ^a   Friedrich, Michael ^c   Meineke, Viktor ^d   Seifert, Markus ^a   Tilgen, Wolfgang ^a   Reichrath, Jörg ^a  

^a SAARLAND UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^c UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^d Sanitatsakademie der Bundeswehr   (Germany)

Author keywords

Cutaneous vitamin D photosynthesis; Environmental hazards; Microbial infections; Review; Skin; UV radiation; Vitamin D endocrine system

Indexed keywords

CALCITRIOL; CISPLATIN; DOXORUBICIN; VITAMIN D;

BONE METABOLISM; CALCIUM METABOLISM; CANCER PREVENTION; CARCINOGENESIS; CELL PROTECTION; CONCENTRATION RESPONSE; ENDOCRINE SYSTEM; GENETIC CONSERVATION; HUMAN; INFECTION PREVENTION; IONIZING RADIATION; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; PHOTOSYNTHESIS; PRIORITY JOURNAL; RADIATION PROTECTION; REVIEW; SKIN PROTECTION; ULTRAVIOLET RADIATION;

ENDOCRINE SYSTEM; HUMANS; INFECTION; SKIN; SKIN PHYSIOLOGY; ULTRAVIOLET RAYS; VITAMIN D;

EID: 33746657735     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (26)

1. Holick MF: Evolution and function of vitamin D. Rec Results Cancer Res 164: 3-28, 2003.
2. Henry HL: Vitamin D hydroxylases. J Cell Biochem 49(1): 4-9, 1992.
3. Nebert DW and Gonzalez FJ: P450 genes: structure, evolution, and regulation. Ann Rev Biochem 56: 945-993, 1987.
4. Jones G, Ramshaw H, Zhang A, Cook R, Byford V, White J and Petkovich M: Expression and activity of vitamin D-metabolizing cytochrome P450s (CYP1a and CYP24) in human non small cell lung carcinomas. Endocrinology 140: 3303-3310, 1999.
5. Tangpricha V, Flanagan JN, Whitlatch LW, Tseng CC, Chen TC, Holt PR, Lipkin MS and Holick MF: 25-hydroxyvitamin D-1alpha-hydroxylase in normal and malignant colon tissue. Lancet 357(9269): 1673-1674, 2001.
6. Lehmann B, Querings K and Reichrath J: Vitamin D and skin: new aspects for dermatology. Exp Dermatol 13(s4): 11-15, 2004.
7. Reichrath J, Rafi L, Rech M, Mitschele T, Meineke V, Gärtner BC, Tilgen W and Holick MF: Analysis of the vitamin D system in cutaneous squamous cell carcinomas (SCC). J Cut Pathol 31(3): 224-231, 2004.
8. Tilgen W, Rass K and Reichrath J: 30 Jahre dermatologische Onkologie. Akt Dermatol 31: 79-88, 2005.
9. Rass K: UV-damage and DNA-repair in basal and squamous cell carcinomas. In: Molecular Mechanisms of Basal Cell and Squamous Cell Carcinomas. Reichrath J (ed.). Landes Biosciences, in press.
10. 3 protect human keratinocytes against the effects of UVB. Arch Dermatol Res 12: 527-534, 2004.
11. 3 in primary human keratinocytes. J Cell Biochem 93(5): 951-967, 2004.
12. 3 inhibits ultraviolet B-induced apoptosis, Jun kinase activation, and interleukin-6 production in primary human keratinocytes. J Cell Biochem 89(4): 663-673, 2003.
13. 3 and analogues protect primary human keratinocytes against UVB-induced DNA damage. J Photochem Photobiol B 78(2): 141-148, 2005.
14. 3 and its analogs. J Steroid Biochem Mol Biol 97(1-2): 137-143, 2005.
15. 3. Rec Results Cancer Res 764: 427-432, 2003.
16. Ravid A, Rubinstein E, Gamady A, Rotem C, Liberman UA and Koren R: Vitamin D inhibits the activation of stress-activated protein kinases by physiological and environmental stresses in keratinocytes. J Endocrinol 173(3): 525-532, 2002.
17. Diker-Cohen T, Koren R, Liberman UA and Ravid A: Vitamin D protects keratinocytes from apoptosis induced by osmotic shock, oxidative stress, and tumor necrosis factor. Ann NY Acad Sci 1010: 350-353, 2003.
18. 3. FASEB J 79(9): 1067-1077, 2005.
19. 3 is a direct inducer of antimicrobial peptide gene expression. J Immunol 173(5): 2909-2912, 2004.
20. Weber G, Heilborn JD, Chamorro Jimenez CI, Hammarsjö A, Törmä H and Ståhle M: Vitamin D induces the antimicrobial protein hCAP18 in human skin. J Invest Dermatol 124(5): 1080-1082, 2005.
21. Zanetti M: Cathelicidins, multifunctional peptides of the innate immunity. J Leukoc Biol 75: 3948, 2004.
22. Zaiou M, Nizet V and Gallo RL: Antimicrobial and protease inhibitory functions of the human cathelicidin (hCAP18/LL-37) prosequence. J Invest Dermatol 120: 810-816, 2003.
23. Dorschner RA, Pestonjamasp VK, Tamakuwala S et al: Cutaneous injury induces the release of cathelicidin antimicrobial peptides active against group A Streptococcus. J Invest Dermatol 117: 9197, 2001.
24. Frohm Nilsson M, Sandstedt B, Sørensen O, Weber G, Borregaard N and Ståhle-Bäckdahl M: The human cationic antimicrobial protein (hCAP18), a peptide antibiotic, is widely expressed in human squamous epithelia and colocalizes with interleukin-6. Infect Immun 67: 2561-2566, 1999.
25. Heilborn JD, Nilsson MF, Kratz G, Weber G, Sorensen O, Borregaard N and Ståhle-Bäckdahl M: The cathelicidin antimicrobial peptide LL-37 is involved in re-epithelialization of human skin wounds and is lacking in chronic ulcer epithelium. J Invest Dermatol 120: 379-389, 2003.
26. Reichrath J and Holick MF: Psoriasis and other skin diseases. In: Feldman D, Pike JW and Glorieux J (eds.). Vitamin D, Second edition. Elsevier, pp. 1791-1804, 2005.